Stockscreener 앱 받기
1.36
0.74%
0.01
전일 마감가:
$1.35
열려 있는:
$1.31
하루 거래량:
178.92K
Relative Volume:
0.29
시가총액:
$67.75M
수익:
$96.63M
순이익/손실:
$-63.32M
주가수익비율:
-0.9315
EPS:
-1.46
순현금흐름:
$-54.55M
1주 성능:
-6.21%
1개월 성능:
-16.56%
6개월 성능:
-49.25%
1년 성능:
-69.16%
1일 변동 폭
$1.31
$1.42
1주일 범위
$1.31
$1.515
52주 변동 폭
$1.31
$4.65
아코야 바이오 Stock (AKYA) Company Profile
명칭
Akoya Biosciences Inc
전화
855.896.8401
주소
100 CAMPUS DRIVE, MARLBOROUGH
AKYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKYA
Akoya Biosciences Inc
|
1.36 | 67.75M | 96.63M | -63.32M | -54.55M | -1.46 |
|
ISRG
Intuitive Surgical Inc
|
507.05 | 177.83B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
226.42 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.59 | 45.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
223.00 | 32.66B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
33.65 | 17.26B | 17.28B | 108.00M | 391.00M | 0.20 |
아코야 바이오 Stock (AKYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2024-08-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-08-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-21 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-02-02 | 개시 | UBS | Buy |
| 2022-11-03 | 개시 | CapitalOne | Overweight |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-06-22 | 개시 | BTIG Research | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-05-11 | 개시 | Canaccord Genuity | Buy |
| 2021-05-11 | 개시 | JP Morgan | Overweight |
| 2021-05-11 | 개시 | Morgan Stanley | Overweight |
| 2021-05-11 | 개시 | Piper Sandler | Overweight |
모두보기
아코야 바이오 주식(AKYA)의 최신 뉴스
Akoya Biosciences And Team SAMBAI Select PhenoCycler-Fusion For Cancer Equity Research - Nasdaq
Akoya Biosciences and Team SAMBAI Announce Selection of the - GlobeNewswire
Major Breakthrough: Akoya Wins $25M Cancer Study to Address Global Health Disparities - Stock Titan
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 30.8% in March - Defense World
Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges By Investing.com - Investing.com South Africa
Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges - Investing.com
This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Akoya Biosciences’ (AKYA) Equal Weight Rating Reaffirmed at Stephens - Defense World
Akoya Biosciences Shares Fall After Downgrade From Stephens - MarketScreener
Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Stephens Downgrades Akoya Biosciences to Equalweight From Overweight, Price Target is $1.80 - Marketscreener.com
Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia
Tikvah to oppose Quanterix-Akoya Biosciences merger - Investing.com India
Tikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya Biosciences - Business Wire
Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Marketscreener.com
Key Investor Fights Back: Quanterix Merger Under Fire Over Valuation Concerns - Stock Titan
Akoya Biosciences (AKYA) to Release Quarterly Earnings on Monday - Defense World
Akoya Biosciences Reports 2024 Financial Results - TipRanks
Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates - MSN
Akoya Biosciences (NASDAQ:AKYA) Receives Overweight Rating from Stephens - Defense World
Akoya Biosciences Shares Down 6.4% After Stock Offering… -June 08, 2023 at 10:10 am EDT - Marketscreener.com
Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges By Investing.com - Investing.com South Africa
Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges - Investing.com Australia
Akoya: Q4 Earnings Snapshot - Milford Mirror
Akoya Biosciences earnings missed by $0.01, revenue topped estimates - Investing.com Australia
Akoya Biosciences, Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq
Akoya Biosciences, Inc. SEC 10-K Report - TradingView
Kent Lake urges Quanterix to address questions regarding Akoya deal -March 17, 2025 at 04:28 pm EDT - Marketscreener.com
Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Amid Pending Acquisition by Quanterix Corporation - Nasdaq
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - GlobeNewswire
Quanterix Merger Under Fire: Top Investor Reveals Shocking 82% Value Disparity - Stock Titan
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call - Bluefield Daily Telegraph
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Brokerages - Defense World
Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger -March 11, 2025 at 10:40 am EDT - Marketscreener.com
Quanterix Merger Under Fire: 7.25% Stakeholder Reveals Shocking Valuation Concerns - StockTitan
Akoya climbs after merger deal with Quanterix - MSN
Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3 - Marketscreener.com
Piper Sandler cuts Akoya Biosciences stock rating to Neutral - Investing.com
Piper Sandler cuts Akoya Biosciences stock rating to Neutral By Investing.com - Investing.com Canada
Quanterix Announces Acquisition of Akoya Biosciences - TipRanks
Quanterix Highlights Benefits Of Akoya Biosciences Acquisition -March 03, 2025 at 06:13 am EST - Marketscreener.com
Can Quanterix's Akoya Acquisition Transform Biomarker Detection and Deliver $1B Revenue? - StockTitan
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 60.1% in February - Defense World
Akoya Biosciences (AKYA) to Release Earnings on Monday - MarketBeat
Akoya Biosciences’ Merger with Quanterix Moves Forward - Investing.com India
Quanterix advances towards Akoya Biosciences acquisition By Investing.com - Investing.com Australia
Akoya Biosciences' Merger with Quanterix Moves Forward By Investing.com - Investing.com South Africa
Quanterix advances towards Akoya Biosciences acquisition - Investing.com
Akoya Biosciences’ Merger with Quanterix Moves Forward By Investing.com - Investing.com UK
아코야 바이오 (AKYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.73%
1.34%
자본화:
|
볼륨(24시간):